eLearning modules

These CPD modules have been developed in partnership with pharmaceutical companies and may contain pharmaceutical promotional information. Please also see: Guidelines Learning

eLearning module index image

The importance of reducing cardiovascular risk in patients with type 2 diabetes

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This eLearning module has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice and Guidelines Learning. Products are discussed.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information
PC-GB-104395 April 2021